Molecular screening: why haven't we started yet?
Villa, E.
American Journal of Gastroenterology 92(12): 2144-2146
1997
ISSN/ISBN: 0002-9270 PMID: 9399742 Document Number: 477106
Document emailed within 1 workday
Related Documents
Hrouda, D.; Davies, J.H.; Kirby, R.S. 1998: Screening for prostate cancer. Key studies have only just started Bmj 316(7148): 1903Fellowes, A.P.; Murphy, J.M.; Wesley, A.W.; Dawson, K.P.; George, P.M. 1991: Molecular screening of cystic fibrosis patients New Zealand Medical Journal 104(921): 415-416
Zlocha, J.; Kovács, L.; Pozgayová, S.; Kupcová, V.; Durínová, S. 2006: Molecular genetic diagnostics and screening of hereditary hemochromatosis Vnitrni Lekarstvi 52(6): 602-608
Seifert, M.H.J.; Kraus, J.ür.; Kramer, B. 2007: Virtual high-throughput screening of molecular databases Current Opinion in Drug Discovery and Development 10(3): 298-307
Herzog, A. 2015: You, Your Health, and HAVEN Connecticut Medicine 79(4): 245-246
Johnson, M.; Lajiness, M.; Maggiora, G. 1989: Molecular similarity: a basis for designing drug screening programs Progress in Clinical and Biological Research 291: 167-171
Wolff, C.; Hörnschemeyer, D.; Skurtopulos, M.; Petersen, N.; Beyer, J.; Seidel, K.; Mutz, A.; Kleesiek, K. 1994: Molecular biological screening of viruses important to transfusion medicine Beitrage Zur Infusionstherapie und Transfusionsmedizin 32: 102-109
Sagan, L.A. 1987: What is hormesis and why haven't we heard about it before? Health Physics 52(5): 521-525
Norris, M. 1992: Operation Haven--one year on Journal of the Royal Naval Medical Service 78(2): 103-105
Feuerstein, P. 2016: I Haven't Got time for the Pain Dentistry Today 35(3): 24
Okano, Y.; Isshiki, G. 1995: Newborn mass screening and molecular genetics of phenylketonuria in east Asia Southeast Asian Journal of Tropical Medicine and Public Health 26(Suppl 1): 123-129
Peleg, L.; Gazit, E.; Goldman, B.; Akstein, E. 1995: Biochemical, molecular and social aspects of carrier screening for Tay-Sachs disease Harefuah 129(11): 475-480
Baker, F.M. 1988: Suicide attempters in new Haven: a ten-year perspective Journal of the National Medical Association 80(8): 889-895
Kauffman, K.S. 1995: Center as haven: findings of an urban ethnography Nursing Research 44(4): 231-236
Irshad, M.; Abbasi, M.A.; Rehman, A.R.; Siddiqui, S.Z.; Ali, M.S.; Ashraf, M.; Ismail, T.; Ahmad, I.; Hassan, S.; Lodhi, M.A.; Jamal, S.B. 2016: Synthesis, biological screening and molecular docking studies of some ethylated sulfonamides having 1,4-Benzodioxane moiety Pakistan Journal of Pharmaceutical Sciences 29(6): 1913-1925
Chávez-Saldaña, M.; Yokoyama, E.; Lezana, J.é L.; Carnevale, A.; Macías, M.; Vigueras, R.M.; López, M.; Orozco, L. 2010: CFTR allelic heterogeneity in Mexican patients with cystic fibrosis: implications for molecular screening Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 62(6): 546-552
Daves, M.L. 1973: Cardiovascular anachronisms. Phrases and concepts that should disappear but haven't JAMA 224(6): 879-883
Byrnes, P.D. 2011: Why haven't i changed that? Therapeutic inertia in general practice Australian Family Physician 40(1-2): 24-28
Fryns, J.P. 1995: Screening for the fragile X syndrome: the necessity of international guidelines for molecular genetics predictive testing in general Genetic Counseling 6(4): 293-296
Wu, Y.; Nishio, H.; Lee, M.J.; Ayaki, H.; Hayashi, A.; Ooba, T.; Ogawa, T.; Sumino, K. 2000: Molecular genetic analysis and mutation screening of the VHL gene in a Japanese family with von Hippel-Lindau disease Kobe Journal of Medical Sciences 46(4): 147-153